Wang, K., Ding, J., Li, X., Guo, W., Zhu, X., Su, Y., . . . Ding, L. (2022). Effects of itraconazole and rifampicin on the pharmacokinetics and safety of youkenafil, a novel phosphodiesterase type 5 inhibitor, in healthy Chinese subjects. European journal of pharmaceutical sciences, 175, 106213. https://doi.org/10.1016/j.ejps.2022.106213
Citace podle Chicago (17th ed.)Wang, Keli, Juefang Ding, Xianjing Li, Wenjing Guo, Xingyu Zhu, Yue Su, Luning Sun, Huan Zhou, a Li Ding. "Effects of Itraconazole and Rifampicin on the Pharmacokinetics and Safety of Youkenafil, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Subjects." European Journal of Pharmaceutical Sciences 175 (2022): 106213. https://doi.org/10.1016/j.ejps.2022.106213.
Citace podle MLA (9th ed.)Wang, Keli, et al. "Effects of Itraconazole and Rifampicin on the Pharmacokinetics and Safety of Youkenafil, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Subjects." European Journal of Pharmaceutical Sciences, vol. 175, 2022, p. 106213, https://doi.org/10.1016/j.ejps.2022.106213.